Catalyst

Slingshot members are tracking this event:

European Commission Designates Zogenix' (ZGNX) ZX008 an Orphan Medicinal Product for Lennox-Gastaut Syndrome

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ZGNX

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords European Commission, Zx008, Orphan Medicinal Product, Lennox-gastaut Syndrome